Abstract:BACKGROUND AND PURPOSE:This study aims to investigate whether and how pharmacological activation of AMP-activated protein kinase (AMPK) improves endothelial function by suppressing mitochondrial ROS-associated endoplasmic reticulum stress (ER stress) in the endothelium. Experimental approach Palmitate stimulation induced mitochondrial fission and ER stress-associated endothelial dysfunction. The effects of AMPK activators salicylate and AICA riboside (AICAR) on mitochondrial ROS production, Drp1 phosphorylation, mitochondrial fission, ER stress, thioredoxin-interacting protein (TXNIP)/NLRP3 inflammasome activation, inflammation, cell apoptosis and endothelium-dependent vasodilation were observed. Key results "Silencing" of TXNIP by RNA interference inhibited NLRP3 inflammasome activation in response to ER stress, indicating that TXNIP was a key link between ER stress and NLRP3 inflammasome activation. AMPK activators salicylate and AICAR prevented ROS-induced mitochondrial fission by enhancing dynamin-related protein 1 (Drp1) phosphorylation (Ser 637) and thereby attenuated IRE-1α and PERK phosphorylation, but their actions were blocked by knockdown of AMPK. Salicylate and AICAR reduced TXNIP induction and inhibited NLRP3 inflammasome activation by reducing NLRP3 and caspase-1 expression, leading to a reduction in IL-1β secretion. As a result, salicylate and AICAR inhibited inflammation and reduced cell apoptosis. Meanwhile, salicylate and AICAR enhanced eNOS phosphorylation and restored the loss of endothelium-dependent vasodilation in the rat aorta. Immunohistochemistry staining showed that AMPK activation inhibited ER stress and NLRP3 inflammasome activation in the vascular endothelium.CONCLUSION AND IMPLICATIONS:Pharmacological activation of AMPK regulated mitochondrial morphology and ameliorated endothelial dysfunction by suppression of mitochondrial ROS-associated ER stress and subsequent TXNIP/NLRP3 inflammasome activation. These findings suggested that regulation of Drp1 phosphorylation by AMPK activation contributed to suppression of ER stress and thus presented a potential therapeutic strategy for AMPK activation in the regulation of endothelium homeostasis.

Acetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signaling

Reduction of Mitochondria-Endoplasmic Reticulum Interactions by Acetylcholine Protects Human Umbilical Vein Endothelial Cells from Hypoxia/Reoxygenation Injury

Inhibition of the Mitochondrial Unfolded Protein Response by Acetylcholine Alleviated Hypoxia/reoxygenation-Induced Apoptosis of Endothelial Cells

[Myocardial Protective Effect of Acetylcholine Against Ischemia/reperfusion Injury and Its Underlying Mechanism].

Acetylcholine attenuates hypoxia/ reoxygenation-induced mitochondrial and cytosolic ROS formation in H9c2 cells via M2 acetylcholine receptor.

Cholinergic Drugs Ameliorate Endothelial Dysfunction by Decreasing O-GlcNAcylation Via M3 AChR-AMPK-ER Stress Signaling.

Acetylcholine Mediates Ampk-Dependent Autophagic Cytoprotection in H9c2 Cells During Hypoxia/Reoxygenation Injury

Acetylcholine protects mesenteric arteries against hypoxia/reoxygenation injury via inhibiting calcium-sensing receptor

Acetylcholine Attenuates Hypoxia/Reoxygenation Injury by Inducing Mitophagy Through PINK1/Parkin Signal Pathway in H9c2 Cells.

Acetylcholine Inhibits Tumor Necrosis Factor Α Activated Endoplasmic Reticulum Apoptotic Pathway Via EGFR‐PI3K Signaling in Cardiomyocytes

Acetylcholine promotes ROS detoxification against hypoxia/reoxygenation-induced oxidative stress through FoxO3a/PGC-1α dependent superoxide dismutase.

Exercise attenuates myocardial I/R injury by regulating endoplasmic reticulum stress and mitophagy through M2AChR

Choline Produces Cytoprotective Effects Against Ischemic Myocardial Injuries: Evidence For The Role Of Cardiac M-3 Subtype Muscarinic Acetylcholine Receptors

Exercise Attenuates Myocardial Ischemia-Reperfusion Injury by Regulating Endoplasmic Reticulum Stress and Mitophagy Through M2 Acetylcholine Receptor.

Choline Ameliorates Cardiac Hypertrophy by Regulating Metabolic Remodelling and UPRmt Through SIRT3-AMPK Pathway

Acetylcholine Attenuated TNF-α-induced Intracellular Ca2+ Overload by Inhibiting the Formation of the NCX1-TRPC3-IP3R1 Complex in Human Umbilical Vein Endothelial Cells.

Acetylcholine inhibits hypoxia-induced tumor necrosis factor-α production via regulation of MAPKs phosphorylation in cardiomyocytes.

Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Endoplasmic Reticulum Stress-Associated Endothelial Dysfunction

Activation of M3 cholinoceptors attenuates vascular injury after ischaemia/reperfusion by inhibiting the Ca(2+) /calmodulin-dependent protein kinase II pathway.

Anisodine Hydrobromide Alleviates Oxidative Stress Caused by Hypoxia/reoxygenation in Human Cerebral Microvascular Endothelial Cells Predominantly Via Inhibition of Muscarinic Acetylcholine Receptor 4

Apelin-13 Protects the Heart Against Ischemia-Reperfusion Injury Through Inhibition of Er-Dependent Apoptotic Pathways in A Time-Dependent Fashion